Abiopharma

New Form DEF 14A - MAIA Biotechnology, Inc. <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001140361-26-013499 <b>Size:</b> 3 MB

BRAZILIAN ELECTRIC POWER CO (AXIA) Files Form 6-K

RYDE GROUP LTD (RYDE) Files Form 6-K

New Form 4/A - GREENLIGHT CAPITAL RE, LTD. <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001385613-26-000054 <b>Size:</b> 5 KB

Financial Statements and Related Announcement: Auditors Comments of Accounts

GRUPO AVAL ACCIONES Y VALORES S.A. (AVAL) Files Form 6-K

NEURONES :

NEURONES: Declaration of transactions on treasury shares (March 30 to April 3, 2026)

Financial Statements and Related Announcement: Discrepancies between unaudited and audited accounts

New Form DEFA14A - SIERRA BANCORP <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001104659-26-040185 <b>Size:</b> 424 KB

ASCENDIS PHARMA A/S (ASND) Files Form 6-K

(50% Neutral) ARLO TECHNOLOGIES, INC. (ARLO) Announces Regulatory Update

New Form DEF 14A - SIERRA BANCORP <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001104659-26-040182 <b>Size:</b> 3 MB

CALEDONIA MINING CORP PLC (CMCL) Files Form 6-K

Natera - 20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform